HealthEquity Debt to Equity Ratio 2014-2024 | HQY
Current and historical debt to equity ratio values for HealthEquity (HQY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. HealthEquity debt/equity for the three months ending October 31, 2024 was 0.50.
| HealthEquity Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-10-31 | $1.36B | $2.13B | 0.64 |
| 2024-07-31 | $1.36B | $2.16B | 0.63 |
| 2024-04-30 | $1.15B | $2.10B | 0.55 |
| 2024-01-31 | $1.13B | $2.04B | 0.56 |
| 2023-10-31 | $1.11B | $1.99B | 0.56 |
| 2023-07-31 | $1.12B | $1.95B | 0.57 |
| 2023-04-30 | $1.12B | $1.92B | 0.58 |
| 2023-01-31 | $1.19B | $1.90B | 0.63 |
| 2022-10-31 | $1.18B | $1.88B | 0.63 |
| 2022-07-31 | $1.21B | $1.87B | 0.65 |
| 2022-04-30 | $1.21B | $1.86B | 0.65 |
| 2022-01-31 | $1.26B | $1.85B | 0.68 |
| 2021-10-31 | $1.23B | $1.87B | 0.66 |
| 2021-07-31 | $1.29B | $1.86B | 0.69 |
| 2021-04-30 | $1.31B | $1.85B | 0.71 |
| 2021-01-31 | $1.33B | $1.38B | 0.97 |
| 2020-10-31 | $1.30B | $1.36B | 0.96 |
| 2020-07-31 | $1.32B | $1.34B | 0.99 |
| 2020-04-30 | $1.52B | $1.04B | 1.46 |
| 2020-01-31 | $1.54B | $1.03B | 1.49 |
| 2019-10-31 | $1.54B | $1.02B | 1.52 |
| 2019-07-31 | $0.08B | $1.02B | 0.08 |
| 2019-04-30 | $0.07B | $0.53B | 0.13 |
| 2019-01-31 | $0.03B | $0.48B | 0.07 |
| 2018-10-31 | $0.02B | $0.46B | 0.05 |
| 2018-07-31 | $0.02B | $0.43B | 0.05 |
| 2018-04-30 | $0.02B | $0.40B | 0.05 |
| 2018-01-31 | $0.02B | $0.35B | 0.07 |
| 2017-10-31 | $0.02B | $0.33B | 0.07 |
| 2017-07-31 | $0.02B | $0.32B | 0.05 |
| 2017-04-30 | $0.01B | $0.29B | 0.04 |
| 2017-01-31 | $0.02B | $0.26B | 0.07 |
| 2016-10-31 | $0.01B | $0.25B | 0.05 |
| 2016-07-31 | $0.01B | $0.24B | 0.05 |
| 2016-04-30 | $0.01B | $0.22B | 0.04 |
| 2016-01-31 | $0.02B | $0.20B | 0.08 |
| 2015-10-31 | $0.01B | $0.20B | 0.07 |
| 2015-07-31 | $0.01B | $0.19B | 0.06 |
| 2015-04-30 | $0.01B | $0.16B | 0.07 |
| 2015-01-31 | $0.02B | $0.14B | 0.10 |
| 2014-10-31 | $0.01B | $0.14B | 0.09 |
| 2014-07-31 | $0.06B | $0.01B | 5.16 |
| 2014-04-30 | $0.00B | $0.00B | 0.00 |
| 2014-01-31 | $0.00B | 0.00 | |
| 2013-10-31 | $0.00B | $0.00B | 0.00 |
| 2013-07-31 | $0.00B | $0.00B | 0.00 |
| 2013-01-31 | $0.05B | $-0.01B | -8.25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.644B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| Nutex Health (NUTX) | United States | $0.256B | 5.10 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |